Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul N Durrington

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Current Opinion in Lipidology|July 13, 2017
Editorial introductionPaul N Durrington
Journal of the American College of Cardiology|August 15, 2020
Family History and Lipoprotein(a) Contribute Independently to Risk Assessment and Clinical ManagementPaul N Durrington
Evidence-Based Medicine|September 25, 2014
With statin co-administration, drugs designed to increase HDL have no impact on cardiovascular outcomesPaul N Durrington
Antioxidants (Basel, Switzerland)|February 27, 2026
Antioxidant Role of High-Density LipoproteinPaul N Durrington
Journal of Clinical Lipidology|February 5, 2011
The first recorded heterozygote for familial hypercholesterolemiaPaul N Durrington
Clinical Chemistry|February 28, 2002
Can measurement of apolipoprotein B replace the lipid profile in the follow-up of patients with lipoprotein disorders?Paul N Durrington
Journal of Clinical Lipidology|May 19, 2023
An update on the first recorded case of familial hypercholesterolaemia: The Charioteer of DelphiPaul N Durrington
Current Opinion in Lipidology|July 8, 2011
Susceptibility of LDL and its subfractions to glycationHandrean Soran, Paul N Durrington
Community Genetics|May 22, 2008
Patients' understandings and experiences of familial hypercholesterolemiaKate Weiner, Paul N Durrington
Circulation|February 15, 2017
Cholesterol Levels Should Play a More Important Role in Identifying Statin RecipientsPaul N Durrington, Handrean Soran
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Current Opinion in Lipidology|July 13, 2017
Editorial introductionPaul N Durrington
Journal of the American College of Cardiology|August 15, 2020
Family History and Lipoprotein(a) Contribute Independently to Risk Assessment and Clinical ManagementPaul N Durrington
Evidence-Based Medicine|September 25, 2014
With statin co-administration, drugs designed to increase HDL have no impact on cardiovascular outcomesPaul N Durrington
Antioxidants (Basel, Switzerland)|February 27, 2026
Antioxidant Role of High-Density LipoproteinPaul N Durrington
Journal of Clinical Lipidology|February 5, 2011
The first recorded heterozygote for familial hypercholesterolemiaPaul N Durrington
Clinical Chemistry|February 28, 2002
Can measurement of apolipoprotein B replace the lipid profile in the follow-up of patients with lipoprotein disorders?Paul N Durrington
Journal of Clinical Lipidology|May 19, 2023
An update on the first recorded case of familial hypercholesterolaemia: The Charioteer of DelphiPaul N Durrington
Current Opinion in Lipidology|July 8, 2011
Susceptibility of LDL and its subfractions to glycationHandrean Soran, Paul N Durrington
Community Genetics|May 22, 2008
Patients' understandings and experiences of familial hypercholesterolemiaKate Weiner, Paul N Durrington
Circulation|February 15, 2017
Cholesterol Levels Should Play a More Important Role in Identifying Statin RecipientsPaul N Durrington, Handrean Soran
Pageof 11